Faruqi & Faruqi, LLP’s national practice focuses on complex civil litigation. The firm practices in the areas of Securities, Merger & Transactional, Shareholder Derivative, Antitrust, Consumer Class Action, and Wage & Hour litigation.
Monday, July 6, 2015
Faruqi & Faruqi Investigation: Humana Inc.
Faruqi & Faruqi, LLP Announces the Investigation of Humana Inc. (HUM) Over the Proposed Sale of the Company to Aetna Inc.
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Humana Inc. (“Humana” or the “Company”) (NYSE:HUM) for potential breaches of fiduciary duties in connection with the sale of the Company to Aetna Inc. for approximately $37 billion in cash and shares. The Company’s stockholders will only receive $125.00 in cash and 0.8375 Aetna common shares for each share of Company common stock they own or $230.11 per share.
However, at least one analyst opinion sets the target price at $230.00 per share and the price per share is expected to continue climbing.
If you own common stock in Humana and wish to obtain additional information and protect your investments free of charge, please fill out the form below or contact F&F'sJuan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330.